Blue Owl Capital Holdings LP 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | Marker Therapeutics, Inc. MRKR | Blue Owl Capital Holdings LP | 1,127,052 9.990% | 572,802 (+103.35%) | Filing |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | Marker Therapeutics, Inc. MRKR | Blue Owl Capital Holdings LP | 554,250 5.180% | 554,250 (New Position) | Filing |